| ProductNum | picture | CAS No. | Name and description | Size | Formula | Quick order |
|---|---|---|---|---|---|---|
| CP000082 |
|
477600-75-2 |
Tofacitinib - 99% |
0 | C16H20N6O | |
| CP006906 |
|
122111-01-7 |
((2R,3R)-3-(Benzoyloxy)-4,4-difluoro-5-oxotetrahydrofuran-2-yl)methyl benzoate - 99% |
0 | C19H14O6F2 | |
| CP001151 |
|
491-67-8 |
Baicalein - 98% |
0 | C15H10O5 | |
| CP007307 |
|
475207-59-1 |
Sorafenib tosylate - 98.0~102.0% |
0 | C28H24ClF3N4O6S | |
| CP007981 |
|
89250-26-0 |
2-(Chloromethyl)-4-(4-nitrophenyl)thiazole - 70% |
0 | C10H7N2O2SCL | |
| CP000326 |
|
1613220-15-7 |
Niraparib Tosylate - 98% |
0 | C26H30N4O5S | |
| CP002620 |
|
1514-85-8 |
2,2-difluoromalonic acid - 98% |
0 | C3H2F2O4 | |
| CP004391 |
|
121-30-2 |
4-Amino-6-chlorobenzene-1,3-disulfonamide - ≥99.0% |
0 | C6H8ClN3O4S2 | |
| CP000191 |
|
123-11-5 |
4-Methoxybenzaldehyde - 99% |
0 | C8H8O2 | |
| CP003851 |
|
114870-03-0 |
Fondaparinux sodium - 99% |
0 | C31H43N3NA10O49S8 | |
| CP008128 |
|
57-67-0 |
Sulphaguanidine - 99% |
0 | C7H10N4O2S | |
| CP003528 |
|
36983-12-7 |
D-p-Methyl-sulfino phenyl ethyl - 98% |
0 | C12H17NO5S | |
| CP005923 |
|
40258-78-4 |
1-Bromoethyl acetate - ≥97% |
0 | C4H7BrO2 | |
| CP005253 |
|
152-47-6 |
4-Amino-N-(3-methoxypyrazin-2-yl)benzenesulfonamide - 99% |
0 | C11H12N4O3S | |
| CP002894 |
|
127-79-7 |
sulfamerazine free acid - 99% |
0 | C11H12N4O2S | |
| CP000931 |
|
29342-05-0 |
Ciclopirox - 98.0~101.0% |
0 | C12H17NO2 | |
| CP000619 |
|
69787-61-0 |
Cyclosporin C - 95% |
0 | C62H111N11O | |
| CP005955 |
|
60-92-4 |
Adenosine Cyclophosphate - 98% |
0 | C10H12N5O6P | |
| CP002393 |
|
117-39-5 |
2-(3,4-Dihydroxyphenyl)-3,5,7-trihydroxy-4H-chromen-4-one - 95% |
0 | C15H10O7 | |
| CP007892 |
|
71963-77-4 |
Artemether - 98% |
0 | C16H26O5 | |
